SUS.L(SUS.L)
SUS.L
No analyst ratings available
No analyst price targets available for SUS.L
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E | FY2029E |
|---|---|---|---|
| Revenue Avg | $122M | $144M | $171M |
| Low | $120M | $135M | $163M |
| High | $123M | $148M | $174M |
| EBITDA Avg | $55M | $65M | $77M |
| Low | $54M | $60M | $73M |
| High | $55M | $66M | $78M |
| EBIT Avg | $54M | $64M | $76M |
| Low | $53M | $60M | $72M |
| High | $55M | $66M | $77M |
| Net Income Avg | $26M | $31M | $36M |
| Low | $26M | $30M | $34M |
| High | $27M | $31M | $37M |
| EPS Avg | $2.18 | $2.50 | $3.00 |
| Low | $2.15 | $2.46 | $2.83 |
| High | $2.19 | $2.59 | $3.08 |
| Analysts (Rev / EPS) | 4 / 4 | 3 / 3 | 1 / 1 |